Description Healthcare resources are finite and priority decisions have to be made by regulatory bodies to align the need, clinical effectiveness, and cost-effectiveness of healthcare interventions and services. Cost-utility analysis (a type of cost-effectiveness...
Description Exposure-response (E-R) analysis to inform optimal dose in early clinical development of oncology products has traditionally relied on adverse event-based clinician-reported Common Terminology Criteria for Adverse Events. As part of a broader effort to...
President’s Award The President’s Award is awarded to individuals who have advanced health related quality of life (HRQL) research and made outstanding contributions to the ISOQOL in one or more of the following areas: Education of professionals, patients or lay...
Thank you to outgoing ISOQOL Board Members President Lori Frank, PhDRAND CorporationVirginia, United StatesTerm: 2019 – 2021 Secretary/Treasurer Joan J. Branin, PhDCalifornia, United StatesTerm: 2017 – 2021 Directors-at-Large Kim Cocks, PhDAdelphi...
The first two week of the live 2021 Annual Conference have been a huge success! If you were not able to join us, registration for the conference remains open through 30 November. However, there will be a 1-2 hour delay from the time of paid registration until you...
